EUVIMEDDescoperă EUVIMED
Open access · CC BY 4.0

Clonal analysis of metachronous double biliary tract cancers

Yuko Omori, Shuichi Aoki, Yusuke Ono, Takashi Kokumai, Shingo Yoshimachi, Hideaki Sato, Akiko Kusaka, Masahiro Iseki, Daisuke Douchi, Takayuki Miura, Shimpei Maeda, Masaharu Ishida and 5 more

The Journal of Pathology · 2024-05 · 263 (1) · 113-127

DOI: 10.1002/path.6265 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2024-03-14. Written by Yuko Omori and 16 co-authors. Institution: Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan. Major MEDLINE topics: Neoplasms, Second Primary, Biliary Tract Neoplasms, Bile Duct Neoplasms. Cited 9 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

The molecular mechanisms underpinning the development of metachronous tumors in the remnant bile duct following surgical resection of primary biliary tract carcinomas (BTCs) are unknown. This study aimed to elucidate these mechanisms by evaluating the clinicopathologic features of BTCs, the alterations to 31 BTC‐related genes on targeted sequencing, and the aberrant expression of p53, p16, SMAD4, ARID1A and β‐catenin on immunohistochemistry. Twelve consecutive patients who underwent resection of metachronous BTCs following primary BTC resection with negative bile duct margins were enrolled. Among the 12 metachronous tumors, six exhibited anterograde growth in the lower portion and six exhibited retrograde growth in the upper portion of the biliary tree. Surgical resection of metachronous BTCs resulted in recurrence‐free survival in seven, local recurrence in five, and death in two patients. Nine achieved 5‐year overall survival after primary surgery. Molecular analyses revealed that recurrently altered genes were: TP53 , SMAD4 , CDKN2A , ELF3 , ARID1A , GNAS , NF1 , STK11 , RNF43 , KMT2D and ERBB3 . Each of these was altered in at least three cases. A comparison of the molecular features between 12 paired primary and metachronous BTCs indicated that 10 (83%) metachronous tumors developed in clonal association with corresponding primary tumors either successionally or phylogenically. The remaining two (17%) developed distinctly. The successional tumors consisted of direct or evolved primary tumor clones that spread along the bile duct. The phylogenic tumors consisted of genetically unstable clones and conferred a poor prognosis. Metachronous tumors distinct from their primaries harbored fewer mutations than successional and phylogenic tumors. In conclusion, over 80% of metachronous BTCs that develop following primary BTC resection are probably molecularly associated with their primaries in either a successional or a phylogenetic manner. Comparison between the molecular features of a metachronous tumor and those of a preceding tumor may provide effective therapeutic clues for the treatment of metachronous BTC. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Neoplasms, Second PrimaryBiliary Tract NeoplasmsBile Duct NeoplasmsHumansPhylogenyMutationBile Ducts

Author keywords

biliary tract cancerintraductal tumor spreadintramural metastasismetachronous biliary tract cancerremnant biliary tract recurrence

Authors and institutions

  • Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
  • Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Division of Gastroenterology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.

ORCID profiles: Yusuke Mizukami, Toru Furukawa

Cite

APA

Omori, Y., Aoki, S., Ono, Y., Kokumai, T., Yoshimachi, S., Sato, H., Kusaka, A., Iseki, M., Douchi, D., Miura, T., Maeda, S., Ishida, M., Mizuma, M., Nakagawa, K., Mizukami, Y., Furukawa, T., & Unno, M. (2024). Clonal analysis of metachronous double biliary tract cancers. The Journal of Pathology, 263(1), 113-127. https://doi.org/10.1002/path.6265

Vancouver

Omori Y, Aoki S, Ono Y, Kokumai T, Yoshimachi S, Sato H, et al. Clonal analysis of metachronous double biliary tract cancers. The Journal of Pathology. 2024;263(1):113-127. doi:10.1002/path.6265

BibTeX
@article{Omori2024,
  author = {Omori, Yuko and Aoki, Shuichi and Ono, Yusuke and Kokumai, Takashi and Yoshimachi, Shingo and Sato, Hideaki and Kusaka, Akiko and Iseki, Masahiro and Douchi, Daisuke and Miura, Takayuki and Maeda, Shimpei and Ishida, Masaharu and Mizuma, Masamichi and Nakagawa, Kei and Mizukami, Yusuke and Furukawa, Toru and Unno, Michiaki},
  title = {Clonal analysis of metachronous double biliary tract cancers},
  journal = {The Journal of Pathology},
  year = {2024},
  volume = {263},
  number = {1},
  pages = {113--127},
  doi = {10.1002/path.6265}
}
Start for free →